Modulation of CSF miRNAs in ALS Phase 2 Study Participants Treated With MSC-NTF Cells (NurOwn®) - BrainStorm – Discover, Innovate, Deliver – Delivering on the Promise of Cellular Therapeutics

Skip to content

Science
Pipeline
- Pipeline
- Pipeline Overview
Patients & Caregivers
About
- Leadership
- Careers
Investors & Media
Contact
- facebook
- linkedin
- twitter
- vimeo

Science
Pipeline
- Pipeline
- Pipeline Overview
Patients & Caregivers
About
- Leadership
- Careers
Investors & Media
Contact
- facebook
- linkedin
- twitter
- vimeo

View All Articles

Modulation of CSF miRNAs in ALS Phase 2 Study Participants Treated With MSC-NTF Cells (NurOwn®)

Presented at the Annual AAN Meeting

CONTACT

Corporate Headquarters
1325 Avenue of Americas 28th Floor
New York City, NY 10019
Phone: +1-201-488-0460

BRAINSTORM

Science
Pipeline
Investors & Media
Patients & Caregivers
Leadership
Careers
Contact

Facebook Linkedin Twitter Vimeo

© Copyright 2019, BrainStorm Cell Limited. All rights reserved. Website by Chauk.

Privacy Policy
Terms of Use
Sitemap

Scroll to Top